MRKR Marker Therapeutics Inc
Company Analysis
Latest News
🔴 Marker Therapeutics falls 5.5% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🟢 Marker Therapeutics is trading 5.26% up today in pre-market as XBI rises 2.06%
Marker Therapeutics is trading 5.26% up at $1.60 in pre-market, following stronger biotechnology-sector sentiment as XBI rises 2.06%. - Shares gained 1.33%...
🟢 Marker Therapeutics is trading 5% up in after-hours trading amid stronger biotechnology sentiment
Marker Therapeutics is trading 5.26% up now at $1.60, aligned with stronger biotechnology sentiment after XBI gained 2.06% and broader risk appetite...
🟢 Marker Therapeutics is trading 6% up today as XBI rises 2.06%
Marker Therapeutics is trading 6% up now at $1.59, appearing supported by stronger biotech sentiment as XBI rises 2.06%. - The stock extended gains after...
🟢 Marker Therapeutics is trading 10.03% up today amid continued speculative momentum
Marker Therapeutics is trading 10.03% up at $1.53, amid continued speculative momentum with no confirmed fresh catalyst identified. - It closed at $1.39 on...
🟢 Marker Therapeutics is trading 5.25% up today
Marker Therapeutics is trading 5.25% up at $1.46, with no new company-specific announcement identified to explain the August 24, 2026 move. - It closed 13.93%...
Marker Therapeutics Gets a $10 Bull Case on a $1.35 Stock — Can a Tiny Cancer Therapy Firm Close That 640% Gap?
Shares of Marker Therapeutics surged 10.7% to $1.35 on August 21 after H.C. Wainwright reiterated its Buy rating and $10 price target — implying roughly 640%...
🟢 Marker Therapeutics is trading 10.66% up today after H.C. Wainwright reaffirmed Buy and $10 target
Marker Therapeutics is trading 10.66% up at $1.35 after H.C. Wainwright reiterated its Buy rating and $10 price target on August 21, 2026, citing progress...
🟢 Marker Therapeutics is trading 6.1% up today after H.C. Wainwright reiterated its Buy rating
Marker Therapeutics is trading 6.1% up now at $1.29 after H.C. Wainwright reiterated its Buy rating and $10 price target on August 21, 2026. - The analyst...
🔴 Marker Therapeutics falls 5.4% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
🟢 Marker Therapeutics is trading 14.35% up today after biotech-sector strength lifted risk appetite
Marker Therapeutics is trading 14.35% up at $1.33 after biotech-sector strength lifted risk appetite on August 19, 2026. • Trading at $1.33 (+14.35%) • XBI is...
Marker Therapeutics narrows loss to $5 million, issues going concern warning
Marker Therapeutics reported a narrowed net loss of $5.0 million for the six months ended June 30, 2026. This result marks an improvement from the $8.5 million...
🟢 Marker Therapeutics is trading 5% up in pre-market
Marker Therapeutics is trading at $1.17, up 5.41% in pre-market after closing at $1.11 on August 13, 2026; no clear company-specific announcement explaining...
🟢 Marker Therapeutics is trading 5% up today ahead of its expected August 13 earnings report
Marker Therapeutics is trading 5% up at $1.18, with investors looking ahead to the company’s expected August 13 earnings report and interim clinical update. -...
Marker Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 13, 2026
Marker Therapeutics is expected to report a narrower loss of $0.22 per share on revenue of approximately $0.60 million, while the stock currently trades at...
🔴 Marker Therapeutics is trading 5% down today
Marker Therapeutics is trading 5.22% down at $1.09 after no clear company-specific announcement or catalyst was identified for August 11, 2026. - The decline...
🟢 Marker Therapeutics is trading 9.65% up today — no clear catalyst identified
Marker Therapeutics is trading 9.65% up at $1.25 after rising from the August 5 close of $1.14, with no clear company-specific catalyst identified. - No fresh...
🔴 Marker Therapeutics is trading 10.6% down today despite no fresh news
Marker Therapeutics is trading 10.6% down today at $1.10 despite no new company-specific headlines or fundamental updates. • The move appears to be...
🔴 Marker Therapeutics is trading 6.5% down today despite no fresh news
Marker Therapeutics is trading 6.5% down at $1.15 despite no fresh company-specific headlines or fundamental updates. • The decline appears to be a standalone...
🔴 Marker Therapeutics is trading 7% down today on profit-taking and thin after-hours liquidity
Marker Therapeutics is trading at $1.14 (-6.96%) in after-hours action following a regular-session gain to $1.22, a move likely driven by profit-taking and...